Alberta, Canada

Sergiy Vshyvenko

This inventor holds 1 USPTO granted patent. Top assignee: Gilead Sciences, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergiy Vshyvenko. Retrieved from https://idiyas.com/inventor/sergiy-vshyvenko-eaaig3jd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sergiy Vshyvenko and HIV Capsid Inhibitor Preparation

Introduction

Sergiy Vshyvenko is an inventor associated with Gilead Sciences, Inc. His patent work includes a process for preparing a compound intended to help prevent or treat infections caused by Retroviridae viruses, including HIV.

Latest Patents

Vshyvenko is associated with 1 patent: “Process of Preparing HIV Capsid Inhibitor.” The disclosure describes a process for preparing a compound useful in the prevention or treatment of a Retroviridae viral infection, including infection caused by human immunodeficiency virus (HIV).

Career Highlights

The available information connects Vshyvenko’s invention to Gilead Sciences, Inc., a company whose research includes antiviral medicines. His patent contribution concerns the preparation of a compound with potential relevance to HIV prevention or treatment.

Collaborations

Vshyvenko’s listed coworkers include Yueh Hwa S. Chang and Jason A. Davy. Their names are associated with the same professional context provided for his patent work.

Conclusion

Sergiy Vshyvenko’s documented patent contribution focuses on preparing an HIV capsid inhibitor compound, reflecting research directed toward addressing viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…